Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis

Journal of Neural Transmission

Volumn 104, Issue 8-9, 1997, Pages 931-941

  Regland, B ^a,c   Germgard T ^b   Gottfries, C G ^a   Grenfeldt, B ^a   Koch Schmidt, A C ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hyperhomocysteinemia; Schizophrenia; Thermolabile methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; THERMOSTABILITY;

EID: 0030723892     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01285561     Document Type: Article

References (54)

1. Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ (1996) Genetic analysis of thermolabile methylene tetrahydrofolate reductase as a risk factor for myocardial infarction. Q J Med 89: 437-444
2. Amos RJ, Amess JAL, Hinds CJ, Mollin DL (1982) Incidence and pathogenesis of acute megaloblastic bone marrow changes in patients receiving intensive care. Lancet ii: 835-839
3. Andreoli VM, Maffei T (1975) Blood levels of S-adenosylmethionine in schizophrenia. Lancet ii: 922
4. Banks RGS, Henderson RJ, Pratt JM (1968) Reactions of gases in solution, part III. Some reactions of nitrous oxide with transition-metal complexes. J Chem Soc (A) 3: 2886-2890
5. Bell IR, Edman JS, Selhub J, Morrow FD, Marby DW, Kayne HL, Cole JO (1992) Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 86: 386-390
6. Bird A (1990) The essentials of DNA methylation. Cell 70: 5-8
7. Botez MI, Reynolds EH (eds) (1979) Folic acid in neurology, psychiatry, and internal medicine. Raven Press, New York
8. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease - probable benefits of increasing folic acid intakes. J Am Med Assoc 274: 1049-1057
9. Brouwer OF, Onkenhout W, Edellbroek PM, de Kom JF, de Wolff FA, Peters AC (1992) Increased neurotoxicity of arsenic in methylenetetrahydrofolate reductase deficiency. Clin Neurol Neurosurg 94: 307-310
10. Bruinvels J, Pepplinkhuizen L (1984) Impaired glycine-serine conversion and increased plasma taurine levels in episodic psychotic patients with psychedelic symptoms. J Psychiatr Res 18: 307-318
11. Christensen B, Guttormsen AB, Schneede J, Riedel B, Refsum H, Svardal A, Ueland PM (1994) Preoperative methionine loading enhances restoration of the cobalamin-dependent enzyme methionine synthase after nitrous oxide anesthesia. Anesthesiology 80: 1046-1056
12. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155
13. Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835
14. Deth RC, Durand CJ, Sharma A, Liu D (1996) Lymphocyte phospholipid methylation is altered in schizophrenia. Biol Psychiatry 39: 504-505
15. Engbersen AM, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ (1995) Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56: 142-150
16. Fekkes D, Pepplinkhuizen L, Verheij R, Bruinvels J (1994) Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis. Psychiatry Res 51: 11-18
17. Freeman JM, Finkelstein JD, Mudd SH (1975) Folate-responsive homocystinuria and "schizophrenia". N Engl J Med 292: 491-496
18. Friberg L, Nordberg GF, Vouk VB (eds) (1979) Handbook on the toxicology of metals. Elsevier/North-Holland Biomedical Press, p 55
19. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-113
20. Godfrey PSA, Toone BK, Carney MWP, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH (1990) Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336: 392-395
21. Gomes-Trolin C (1996) Transmethylation mechanisms in dementia, schizophrenia and bipolar disorders. Thesis, University of Uppsala, Sweden
22. Goyette P. Sumner JS, Milos R, Duncan AMW, Rosenblatt DS, Matthews RG, Rozen R (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet 7: 195-200
23. Goyette P, Frosst P, Rosenblatt DS, Rozen R (1995) Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 56: 1052-1059
24. Guttormsen AB, Refsum H, Ueland PM (1994) The interaction between nitrous oxide and cobalamin. Biochemical effects and clinical consequences. Acta Anaesthesiol Scand 38: 753-756
25. Harris AE (1988) Physical disease and schizophrenia. Schizophr Bull 14: 85-96
26. Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shimoike H, Kinoshita M (1996) Molecular variant of 5,10-methylene tetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis 121: 293-294
27. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93: 7-9
28. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJM, Rozen R, Blom HJ (1996) Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58: 35-41
29. Le Bel CP, Schatz RA (1989) Effect of toluene on rat synaptosomal phospholipid methylation and membrane fluidity. Biochem Pharmacol 38: 4005-4011
30. McKeever MP, Weir DG, Molloy A, Scott JM (1991) Betaine-homocysteine methyltransferase: organ distribution in man, pig, and rat and subcellular distribution in the rat. Clin Sci 81: 551-556
31. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM (1995) Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345: 149-151
32. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, et al (1995) An international two-stage genome-wide search for schizophrenia susceptibility genes. Nature Genet 11: 321-324
33. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338: 131-137
34. 12. Br J Anaesth 59: 3-13
35. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley Jr GP, Adams Jr MJ (1996) 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63: 610-614
36. Pasquier F, Lebert F, Petit H, Zittoun J, Marquet J (1994) Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 57: 765-766
37. Regland B, Johansson BV, Gottfries CG (1994) Homocysteinemia and schizophrenia as a case of methylation deficiency. Case report. J Neural Transm [Gen Sect] 98: 143-152
38. Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M (1995) Homocysteinemia is a common feature of schizophrenia. J Neural Transm [Gen Sect] 100: 165-169
39. Reynolds EH, Carney MWP, Toone BK (1984) Methylation and mood. Lancet ii: 96-98
40. Riggs KM, Spiro III A, Tucker K, Rush D (1996) Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 63: 306-314
41. Sargent III T, Kusubov N, Taylor SE, Budinger TF (1992) Tracer kinetic evidence for abnormal methyl metabolism in schizophrenia. Biol Psychiatry 32: 1078-1090
42. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH. Wolf PA, Schaefer EJ, Rosenberg IH (1995) Plasma homocysteine and extracranial carotid stenosis in the Framingham heart study. N Engl J Med 332: 286-291
43. Selker EU (1990) DNA methylation and chromatin structure: a view from below. TIBS 15: 103-107
44. Smythies JR, Alarcon RD, Morere D, Monti JA, Steele M, Tolbert LC, Walter-Ryan WG (1986) Abnormalities of one-carbon metabolism in psychiatric disorders: study of methionine adenosyltransferase kinetics and lipid composition of erythrocyte membranes. Biol Psychiatry 21: 1391-1398
45. Smythies J, Gottfries C-G, Regland B (1997) Disturbances of one-carbon metabolism in neuropsychiatric disorders: a review. Biol Psychiatry 41: 230-233
46. Stabler SP, Marcell PD, Poedell ER, Allen RH (1987) Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 162: 185-196
47. Stabler SP, Lindenbaum J, Savage DG, Allen RH (1993) Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 81: 3404-3413
48. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMG, Borm GF, Wouters MGAJ, Eskes TKAB (1994) Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43: 1475-1480
49. Tsuang MT, Perkins K, Simpson JC (1983) Physical diseases in schizophrenia and affective disorder. J Clin Psychiatry 44: 42-46
50. van den Berg M, van der Knaap MS, Boers GHJ, Stehouwer CDA, Rauwerda JA, Valk J (1995) Hyperhomocysteinemia; with reference to its neuroradiological aspects. Neuroradiology 37: 403-411
51. van der Put NMJ, Steegers-Theunissen RPM, Frosst F, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346: 1070-1071
52. Weinberger DR (1995) Schizophrenia. From neuropathology to neurodevelopment. Lancet 346: 552-557
53. Weinshilboum RM (1984) Human pharmacogenetics of methyl conjugation. Fed Proc 43: 2303-2307
54. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Shields DC, Scott JM (1995) A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 88: 763-766